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Abstract 
The pyridine nucleotide transhydrogenase of Escherichia coli catalyzes the reversible transfer of hydride ion equivalents 
between NAD + and NADP ÷ coupled to the translocation of protons across the cytoplasmic membrane. It is composed of 
two subunits (a, [3) organized as an et2[~ 2 tetramer. This brief review describes the use of site-directed mutagenesis to
investigate he structure, mechanism and assembly of the transhydrogenase. This technique has located the binding sites for 
NAD(H) and NADP(H) in the a and [3 subunits, respectively. Mutagenesis has shown that the cysteine residues of the 
enzyme are not essential for its function, and that inhibition of the enzyme by sulfhydryl-specific reagents must be due to 
perturbation of the three-dimensional structure. The sites of reaction of the inhibitors N,N'-dicyclohexylcarbodiimide and 
N-(1-pyrene)maleimide have been located. Selective mutation and insertion of cysteine residues followed by cupric 
o-phenanthrolinate-induced disulfide crosslinking has defined a region of interaction between the et subunits in the 
holoenzyme. Determination of the accessibility of selectively inserted cysteine residues has been used to determine the 
folding pattern of the transmembrane h lices of the [3 subunit. Site-directed mutagenesis of the transmembrane domain of 
the 13 subunit has permitted the identification of histidine, aspartic acid and asparagine residues which are part of the 
proton-pumping pathway of the transhydrogenase. Site-directed mutagenesis and amino acid deletions have shown that the 
six carboxy terminal residues of the a subunit and the two carboxy terminal residues of the [3 subunit are necessary for 
correct assembly of the transhydrogenase in the cytoplasmic membrane. © 1998 Elsevier Science B.V. 
Keywords: Transhydrogenase; Proton pumping; Proton pathway; Pyridine nucleotide-binding site; Site-directed mutagenesis; Inhibition 
site 
1. Introduction 
Pyridine nucleotide transhydrogenase i  a proton 
pump which catalyzes the reversible reaction 
Ho+~t + NADP + + NADH~,~NADPH + NAD + + Hi + 
where reduction of NADP + by NADH is linked to an 
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inward translocation of protons from the periplasm 
(in bacteria) or cytosol (mammalian cells) into the 
cytosol or mitochondrial matrix, respectively. In the 
presence of an electrochemical proton gradient gener- 
ated by another proton pump, the apparent equilib- 
rium of the reaction is shifted strongly towards 
formation of NADPH and NAD +, and the rate of 
reduction of NADP + by NADH is increased 10-fold. 
Proton translocation coupled to the reduction of 
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NAD ÷ by NADPH is driven by the difference in the 
binding energies of the reactants (NADPH and 
NAD ÷) and the products (NADP ÷ and NADH). 
Since binding of NADPH and NADP ÷, but not of 
NADH and NAD ÷, alter the conformation of the 
enzyme, it is likely that the difference in binding 
energies of NADPH and NADP ÷ is the principal 
driving force for proton pumping [1-3]. The pyridine 
nucleotide transhydrogenase of Escherichia coli is 
composed of two subunits, a (510 residues) and 13 
(462 residues), organized as an et2132 tetramer [5-7]. 
The relative simplicity of this structure makes the 
enzyme an excellent system in which to study the 
mechanism of proton pumping. Three domains are 
recognized in transhydrogenases [2,7,8]. Domains I
and III are extramembrane domains carrying the 
NAD(H)- and NADP(H)-binding sites, respectively. 
Domain II is inserted in the bacterial cell or mito- 
chondrial inner membrane. The properties of trans- 
hydrogenases have been reviewed recently by Hatefi 
and Yamaguchi [2] and Olausson et al. [7]. 
Site-directed mutagenesis allows specific replace- 
ment of selected amino acid residues by other amino 
acids. This permits investigation of the role of these 
amino acids in a protein. As outlined in this brief 
review, we have used this technique to study the 
structure, mechanism and assembly of the pyridine 
nucleotide transhydrogenase of E. coli. 
2. Mutagenesis of the pyridine nucleotide- 
binding sites 
The amino acid sequence of the transhydrogenase 
revealed a putative pyridine nucleotide-binding site 
on the a and the [3 subunits [4,5,9]. The GXGXXG 
motif beginning at res idue  otGly 172 is found at the 
first [3-a turn of the [3oL[3-fold typical of dinucleo- 
tide-binding enzymes [10] (Fig. 1). The pyrophos- 
phate bridge of the dinucleotide binds at this turn. 
Conserved glycine and aspartate residues at positions 
188 and 195 are typical of NAD(H)-binding sites 
(Fig. 1), and indicate that the NAD(H)-binding site is 
on the a subunit. The sequence motif GXGXXV 
beginning at residue [3Gly 314 is more typical of 
NADP(H)-binding sites [9,11]. The presence of 
conserved residues ([3Ala 327, [3Gly 337, [3His 34s and 
[3Arg 35°) shared with other NADP(H)-binding en- 
zymes [9,11] (Fig. l) support he assignment of the 
NADP(H)-binding site to the [3 subunit of the trans- 
hydrogenase. 
TH (NAD site) GAGVAGLAAIGAANSLG-A-  IVRAFD TRPEVKEQVQSM 
174 176 188 19S 
Alco DH (Horse) 
Glyc DH (Pig) 
L ipo DH (Human) 
Lact DH (Pig) 
GLGGVGLSVIMGCKAAGAA-R I  IGVD INKDKFAKAKEV 
GFGRIGRLVTRAAFNSGKVD IVAIND PF IDLHYMVYMF 
GAGVIGVELGSVWQRLG-AD-VTAVE FLGHVGGVGIDM 
GVGAVGMACAI  S ILGKELADE IALVDVMEDKLKGEMMD 
TH (NADP site) G YGMAVAQAQYPVAE I TEKLRARG INVRFGIH PVAG-R 
314 329 327 337 345 350 
GSH red (E.coli) GAGYIAVEL  .... AGVINGL- - -GAKTHLFVRKHAPLR 
Thio red (E.coli) GGGNTAVEE .... ALYLSN .... IASEVHLIHRRDGFR 
Tryp red GGGFISVEF  .... AG IFNAYKPVGGKVTLCYRNNPILR  
Mer red(Shigel la) GSSVVALEL  .... AQAFARL- - -GAKVT ILARSTLFFR 
TH (Beta 274-311) GFGTDGSSTGDDQEVGEHREITAEETAEr.r .KNSHSVII  
274 276 
Fig. 1. Comparison of amino acid sequences at NAD(H)- and NADP(H)-binding sites of several enzymes. Conserved amino acids are in bold letters. Alco 
DH, alcohol dehydrogenase; Glyc DH, glyceraldehyde-3-phosphate dehydrogenase; Lipo DH, lipoamide dehydrogenase; Lact DH, lactate dehydrogenase; 
GSH red, glutathione r ductase; Thio red, thioredoxin reductase; Trp red, trypanothione r ductase (Trypanosoma); Mer red, mercuric reductase; TH, E. coli 
pyridine nucleotide transhydrogenase. 
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Site-directed mutagenesis has revealed the impor- 
tance of the conserved residues of the putative 
binding sites. Mutagenesis of the first glycine residue 
(t~Gly 172 or [3Gly 314) in the GXGXXG(V) motifs 
resulted in complete loss of catalytic activity 
[5,12,13]. The effects of the mutation in the [3 subunit 
were particularly interesting since the NADP(H)- 
induced cleavage of the 13 subunit at [3Arg 265 by 
trypsin was abolished [5] thus supporting the assign- 
ment of NADP(H) site to the [3 subunit. Mutations at 
oLGly 174, [3Va1319, [3Gly 337 and [3His 345 had less 
drastic effects [13,14]. Mutation of [3mrg 35° abolished 
catalytic activity [ 13]. This residue probably interacts 
with the 2'-phosphate of the substrate NADP(H). 
The covalently modifying nucleotide analog 5'-(p- 
fluorosulfonylbenzoyl)adenosine (FSBA) was used 
by Hatefi and co-workers [15,16] to identify residues 
involved in the substrate-binding sites of the mito- 
chondrial pyridine nucleotide transhydrogenase. Two 
tyrosine residues, Tyr 245 and Tyr 1°°6, were specifical- 
ly modified resulting in inhibition of the enzyme. 
These residues are equivalent to o~Tyr 226 and [3Tyr 431 
in the E. coli transhydrogenase. Mutagenesis has 
revealed that neither amino acid is essential for 
catalytic activity in the E. coli enzyme [17]. Inhibi- 
tion by FSBA must therefore be due to the intro- 
duction of a sterically hindering group at the active 
site. An analogous effect was produced by covalent 
modification of the NAD(H) site with N,N'- 
dicyclohexylcarbodiimide (DCCD). This reagent 
modified oLAsp 232, etGlu 238 and c~Glu 24° with loss of 
activity (Glu 257, equivalent o E. coli otGlu 238, was 
modified in the mitochondrial enzyme [16]). Muta- 
genesis showed that none of these residues was 
essential for catalytic activity [18]. The presence of 
the FSBA- and DCCD-modifiable residues at the 
active site is clearly seen in a model of the NAD- 
binding site [12]. 
The [3 subunit contains a second GXGXXG motif 
starting at [3Gly 274. The possibility that this might be 
a second nucleotide-binding site on the [3 subunit was 
examined since indirect evidence had been obtained 
that a second site was present on the [3 subunit [19]. 
Thus, the [3 subunit of the transhydrogenase when 
bound to NAD-agarose was cleaved by trypsin only 
in the presence of NADP(H). This result suggested 
that the [3 subunit had binding sites both for 
NADP(H) and NAD. Mutagenesis of [3Gly 274 and 
[3Gly 276 had little effect on catalytic activities [13]. 
Thus, the GXGXXG motif at [3Gly 274 is unlikely to 
be part of a pyridine nucleotide-binding site. This is 
consistent with the absence of conserved 'down- 
stream' residues typical of a NAD(H)-binding site. 
3. Mutagenesis of cysteine residues 
Reaction of the E. coli transhydrogenase with 
sulfhydryl-specific reagents results in inhibition of 
catalytic activity [20]. It has been suggested that 
hydride transfer between the two pyridine nucleotide 
substrates involves reduction and oxidation of a pair 
of sulfhydryl residues ufficiently close to permit the 
formation of a disulfide bond [21]. Mutation of the 
cysteine residues has provided information on both 
the structure and mechanism of the enzyme [22,23]. 
E. coli transhydrogenase contains seven cysteine 
residues, five in the o~ subunit (otCys 292, t~Cys 339, 
t~Cys 395, otCys 397 and oLfys 435) and two in the [3 
subunit ([3Cys 147 and [3Cys26°). A cysteine-free n- 
zyme was generated in which all cysteine residues 
had been replaced by serine or threonine residues. 
Since it retained catalytic activities at least 30% of 
those of nonmutant transhydrogenase [22], hydride 
transfer between the two substrates must not involve 
intermediary reduction/oxidation f a pair of sulf- 
hydryl residues. It has been shown recently that there 
is direct transfer of hydride ion equivalents between 
the pyridine nucleotide substrates [24]. By using 
mutants in which only selected cysteine residues were 
retained, it was shown that the likely site of reaction 
of sulfhydryl reagents leading to inhibition of cata- 
lytic activity is [3Cys 26° [23]. As with FSBA and 
DCCD, inhibition must be due to perturbation of the 
structure of the enzyme since mutation of [3Cys 26° 
has little effect on enzyme activity. 
Site-directed cysteine mutants were used in two 
further structural studies. The three-dimensional 
structures of relatively few membrane nzymes are 
known. Thus, other methods have been employed to 
provide structural information. Methods have been 
developed to take advantage of the reactivity of the 
thiol groups of cysteine residues in enzymes. For 
example, cross-linking studies had shown that et 2, et[3 
and [32 dimers are generated by crosslinking of the 
subunits of the E. coli transhydrogenase [6]. This, 
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together with radiation inactivation analysis indicates 
that the native enzyme is an 12/,2132 tetramer. The a 2 
dimers were readily generated by oxidation of sulf- 
hydryl pairs with cupric o-phenanthrolinate. Mutation 
of aCys 395 and aCys 397 prevented isulfide bond 
formation which gave the crosslinked a:  dimer. 
Thus, the two a subunits of the holoenzyme interface 
in the region of these two cysteine residue [23]. 
Hydropathy plots indicate that the amino terminal 
region of the [3 subunit to residue 260 is trans- 
membranous [25]. Models of the topology of this 
region predict that eight or six transmembrane a-
helices are present [25,26]. Examination of the 
reactivity of native cysteine residues, or of those 
inserted in selected regions by site-directed muta- 
genesis, with 3-(N-maleimidyl propionyl)biocytin or
fluorescent sulfhydryl-specific reagents revealed a 
labelling pattern supportive of the eight a-helices 
model [27]. 
The reagent N-(1-pyrene)maleimide has been 
found to be a useful reagent to investigate some 
aspects of the structure of proteins. It forms eximers 
(excited-state dimers) after reaction with membrane 
proteins such as the CaZ+-ATPase of sarcoplasmic 
reticulum [28] and the lactose permease of E. coli 
[29]. Eximers are formed if the pyrene ring systems 
are within 0.35 nm and in the correct orientation. 
Thus, the proximity of cysteine residues in pyrene 
maleimide-treated proteins can be determined by 
appearance of an eximer band. This approach was 
applied to various mutants of the E. coli trans- 
hydrogenase retaining one or more of the original 
cysteine residues present [23]. An eximer band was 
formed even with cysteine-free transhydrogenase. 
Thus, there are significant limitations in the use of 
this reagent o study membrane protein structure. 
4. Mutagenesis of domain II 
Domain II is the transmembrane domain of the 
transhydrogenase and must contain the pathway by 
which protons are pumped across the membrane. In 
E. coli, domain II is composed of the C-terminal 100 
residues of the a subunit and the N-terminal 260 
residues of the [3 subunit. This region of the a 
subunit is organized as four transmembrane a- 
helices. The [3 subunit region contains eight trans- 
membrane a-helices [27]. The topology of domain II 
is shown in Fig. 2. 
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Fig. 2. Model of the topology of the transmembrane domains (domain II) of the a and [3 subunits of the E. coli transhydrogenase. Putative amino acids of 
the proton pathway are ringed in bold. Conserved amino acid residues which have been mutated are indicated with a stippled circle. Mutated semi- or 
nonconserved amino acids are shown in stippled boxes. The DCCD-modifiable [3Glu j°'4 is indicated. 
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The pathways by which protons are pumped across 
membranes are still uncertain although the recent 
crystal structures of cytochrome c oxidase and bac- 
teriorhodopsin [30,31] have provided some clues. 
Protons are transferred most effectively through 
hydrogen bonds, particularly in a nonpolar environ- 
ment such as the transmembrane regions of proteins. 
Thus, a hydrogen-bonded network acting as a relay 
system to translocate protons from one side of the 
membrane to the other would be expected. Such a 
system also needs a mechanism by which a con- 
formational change mediated by a redox change, 
ligand binding or photoexcitation can induce changes 
in the pK a of ionizable amino acids. Conserved 
ionizable amino acid residues were mutated to iden- 
tify residues involved in the proton pathway through 
the membrane domain (domain II) of the pyridine 
nucleotide transhydrogenase of E. coli. Mutation of 
otHis 45°, oLArg 5°2, [3Glu 82, [3Lys 145, ~His 16° and 
[3Asp 213 produced relatively small changes in hydride 
transfer and proton pumping activities [26]. By 
contrast, most mutants of [3His 91 were more severely 
affected with the exception of [3H91N [26,32] (Table 
1). This mutant was particularly interesting since it 
Table 1 
Catalytic and proton-pumping activities of membrane 
of the putative proton pathway 
vesicles of mutants 
Mutant Catalytic Proton-pumping 
activity (%) activity (%) 
Nonmutant 100 100 
aH450T 17 51 
aR502S 71 93 
3E82Q 63 85 
3E82K 79 66 
3H91S 19 11 
3H91T 11 8 
3H91C 12 7 
3H91K 4 20 
3H91D 15 9 
3H91N 80 7 
3K145T 29 71 
3H161S 90 100 
~H161T 88 108 
IH161C 59 94 
ID213N 92 44 
3D213H 82 34 
~C260S 78 57 
Catalytic and proton-pumping activities are expressed as percentages of
the specific activity in nonmutant membranes. The data were taken from 
Refs. [26,32]. 
showed an 'uncoupled phenotype', that is, little loss 
of catalytic activity while proton translocation was 
abolished. (The low proton translocation activity seen 
in Table 1 is due to the activity of the chromosomally 
encoded normal transhydrogenase.) Subsequently, we 
have mutated the remaining conserved polar residues 
of domain II. The catalytic and proton-translocating 
activities varied from 50% to near normal evels for 
all mutants, with the exception of those of [3Asn 222. 
Catalytic activity and proton translocation were re- 
duced to near background levels in [3N222A. Al- 
though nothing is known about the organization of 
the transmembrane h lices of domain II, it is worth 
noting that [3His 91 and ~Asn 222 are at a similar level 
in the membrane, as modeled in Fig. 2. This suggests 
that helices 7 and 11 might interact to form the 
proton pathway. 
Mutation of some other semiconserved residues of 
domain II (Fig. 2) did not reveal further significant 
residues. Of interest, mutation of [3Glu 124, the residue 
in the [3 subunit labelled by DCCD [27], reduced 
catalytic activity by 50% but had little effect on 
proton translocation. 
In summary, of conserved charged and other polar 
residues, only [3His 91 and ~Asn 222 are essential for 
normal catalytic and/or proton-translocation ac- 
tivities. The mutant [3H91K contains tightly bound 
NADP + and the [3 subunit is susceptible to cleavage 
by trypsin at [3Arg 265 without addition of NADP(H) 
[33]. As discussed in Section 1, proton pumping is 
probably driven by the difference in binding energies 
of NADPH and NADP +. Thus, the properties of this 
mutant provide a linkage between the putative 
proton-translocating residue [3His 91, the binding of 
NADP(H) at the catalytic site, and the change in 
enzyme conformation on NADP(H) binding, which is 
probably associated with proton pumping. Also link- 
ing this residue with conformational change are the 
properties of the [~H91C, T and S mutants. These 
mutants were unable to undergo the NADP(H)-in- 
duced conformational change [32]. Yamaguchi and 
Hatefi [34] have proposed that ~Asp 213 is involved in 
proton translocation since the [3D213I mutant showed 
reduced catalytic and proton translocation activities, 
and had a higher affinity for NADPH. Several 
conserved acidic residues in domain III ([3Glu 361, 
[3Glu  371, ~G1H 374, [3Asp  383, ~Asp 392) were mutated 
by Mueller et al. [35]. Only [3Asp 392 mutants were 
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significantly affected in catalytic activity and proton 
translocation. 
5. Effect of deletions on assembly of the 
transhydrogenase 
By studying a series of deletion mutants in which 
various regions of the transhydrogenase w re deleted, 
it was shown that assembly of the 13 subunit into the 
enzyme was contingent on the insertion of o~ subunits 
into the membrane [36]. The highly nonpolar domain 
II region of the a subunit terminates in a 10-amino 
acid segment which is highly polar and contains four 
positively charged residues (Fig. 2). Premature termi- 
nation of the oL subunit six amino acid residues from 
the carboxy terminal end resulted in complete loss of 
enzyme activity. The subunits were assembled in the 
membrane, but the conformation of the 13 subunit was 
perturbed [37]. Systematic truncation and site-di- 
rected mutagenesis revealed that at least one positive 
charge is required in this region for efficient assembly 
of the two subunits to give a functional enzyme, and 
that t~Phe 5°7, although not affecting assembly, was 
essential for activity. The role of the carboxy terminal 
region in the assembly of the 13 subunit was examined 
by introduction of chain-terminating codons into 
transhydrogenase-encoding plasmid DNA. Deletion 
of the two carboxy terminal amino acids (13Ala 461 
and 13Leu 462) prevented incorporation of both c~ and 
[3 subunits into the membrane. A series of site- 
directed mutants of these two amino acids was 
constructed. The mutations had relatively minor 
effects on catalytic activity. Thus, it is unlikely that 
these residues have a direct catalytic role but are 
important in maintaining the native conformation of 
the transhydrogenase. 
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